![Cho Hee Yun](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Cho Hee Yun formerly worked at Gilead Sciences, Inc., as Executive Director-Clinical Research, Ventyx Biosciences, Inc., as Vice President-Clinical Development, and Pliant Therapeutics, Inc., as Senior Vice President-Clinical Development from 2024 to 2025.
Dr. Yun received her undergraduate degree and doctorate degree from Seoul National University.
Eerdere bekende functies van Cho Hee Yun
| Bedrijven | Functie | Einde |
|---|---|---|
| PLIANT THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-05-2025 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | - |
| VENTYX BIOSCIENCES, INC. | Corporate Officer/Principal | - |
Opleiding van Cho Hee Yun
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
4
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Seoul National University
 Seoul National University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pliant Therapeutics, Inc.
 Pliant Therapeutics, Inc. BiotechnologyHealth Technology Operates as biopharmaceutical company focuses on discovering and developing novel therapies for the treatment of fibrosis | Health Technology |
Ventyx Biosciences, Inc.
 Ventyx Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops oral therapies for patients with autoimmune, inflammatory and neurodegenerative diseases | Health Technology |
